Teradyne (NASDAQ:TER) is currently in Phase 2 of its 18-phase Adhishthana cycle on the weekly charts. While recent optimism has surfaced following Goldman Sachs' upgrade of the stock from Sell to Buy, the stock's internal cycle structure suggests that hidden risks may be developing beneath the surface. Let's examine Teradyne through the lens of the Adhishthana framework to understand why this phase may not be as supportive as it appears.Analysing Teradyne Stock's Phase 2 StructureUnder the Adhishthana Princ ...